本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Kiniksa Pharmaceuticals Ltd.

21.76
-0.0900-0.41%
盘后:21.760.00000.00%19:26 EDT
成交量:49.40万
成交额:1,067.63万
市值:15.81亿
市盈率:-35.98
高:21.79
开:21.42
低:21.33
收:21.85
分时
5日
日K
周K
月K
季K
年K
1分
5分
10分
15分
30分
1小时
2小时
更多
分时
5日
日K
周K
月K
季K
年K
1分
5分
10分
15分
30分
1小时
2小时
2020/04/21

重要事件披露

Current report, items 7.01 and 9.01
2020/04/09

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/04/06

员工持股计划

Securities to be offered to employees in employee benefit plans
2020/03/04

年度报告

Annual report [Section 13 and 15(d), not S-K Item 405]
2020/02/25

重要事件披露

Current report, items 2.02 and 9.01
2020/02/13

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/13

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/13

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/12

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/11

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/04

重要事件披露

Current report, item 5.02
2020/01/12

重要事件披露

Current report, items 2.02, 7.01, and 9.01
2019/12/15

重要事件披露

Current report, items 5.02 and 9.01
2019/11/13

重要事件披露

Current report, item 5.02
2019/11/04

季度报告

Quarterly report [Sections 13 or 15(d)]
2019/10/27

重要事件披露

Current report, items 2.02 and 9.01
2019/09/09

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/08/12

季度报告

Quarterly report [Sections 13 or 15(d)]
2019/08/11

重要事件披露

Current report, items 2.02, 7.01, and 9.01
2019/06/06

持股变动声明

Statement of changes in beneficial ownership of securities

如果下载按钮点击无跳转,请点击右上角菜单选择 “在浏览器打开”